These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17373924)

  • 1. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
    Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
    Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
    Anandh U; Thomas PP; Shastry JC; Jacob CK
    J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
    Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
    Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
    McNulty CA; Bowen JK; Williams AJ
    Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.
    Charest AF; McDougall J; Goldstein MB
    Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure.
    Agarwal SK; Irshad M; Dash SC
    J Assoc Physicians India; 1999 Feb; 47(2):183-5. PubMed ID: 10999085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
    Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
    Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.
    Mat O; Mestrez F; Beauwens R; Muniz-Martinez MC; Dhaene M
    Hemodial Int; 2006 Jan; 10(1):49-55. PubMed ID: 16441827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response of intradermal hepatitis B vaccination at lower dose versus intramuscular vaccination at double standard dose in predialytic chronic renal failure patients.
    Somboonsilp W; Eiam-Ong S; Tungsanga K; Tirawatanapong T
    J Med Assoc Thai; 2003 Dec; 86(12):1122-7. PubMed ID: 14971519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
    Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
    Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
    Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of anti-HBV vaccine efficacy given intradermally and intramuscularly in hemodialysis patients].
    Miłkowski A; Wyrwicz G; Kubit P; Smoleński O
    Przegl Lek; 2000; 57(11):628-34. PubMed ID: 11293210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial.
    Bock M; Barros E; Veronese FJ
    Nephrology (Carlton); 2009 Apr; 14(3):267-72. PubMed ID: 19207871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.
    Idilman R; Colantoni A; De Maria N; Ustun C; Sam R; Ing TS; Akan H; Koc H; Van Thiel DH
    Hepatogastroenterology; 2003; 50(49):217-21. PubMed ID: 12630026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
    Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
    Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.